Concepts (95)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Botulinum Toxins, Type A | 3 | 2025 | 130 | 1.490 |
Why?
|
| Tics | 2 | 2025 | 53 | 1.490 |
Why?
|
| Neuromuscular Agents | 2 | 2025 | 66 | 1.450 |
Why?
|
| Tremor | 3 | 2021 | 127 | 1.360 |
Why?
|
| Dystonia | 5 | 2023 | 165 | 1.230 |
Why?
|
| Botulinum Toxins | 3 | 2025 | 113 | 1.130 |
Why?
|
| Tic Disorders | 2 | 2025 | 84 | 1.030 |
Why?
|
| Dystonic Disorders | 3 | 2023 | 92 | 0.990 |
Why?
|
| Movement Disorders | 3 | 2022 | 218 | 0.860 |
Why?
|
| Classical Lissencephalies and Subcortical Band Heterotopias | 1 | 2023 | 14 | 0.800 |
Why?
|
| Brain Diseases | 2 | 2022 | 299 | 0.730 |
Why?
|
| Chorea | 1 | 2021 | 33 | 0.660 |
Why?
|
| Migraine with Aura | 1 | 2021 | 16 | 0.660 |
Why?
|
| Hemiplegia | 1 | 2021 | 40 | 0.660 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 64 | 0.650 |
Why?
|
| Jaw Diseases | 1 | 2020 | 4 | 0.650 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 781 | 0.570 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2026 | 3763 | 0.380 |
Why?
|
| Aromatic-L-Amino-Acid Decarboxylases | 1 | 2026 | 21 | 0.230 |
Why?
|
| Infant | 6 | 2026 | 13352 | 0.220 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2026 | 115 | 0.210 |
Why?
|
| Phenotype | 3 | 2024 | 4497 | 0.210 |
Why?
|
| Receptors, AMPA | 1 | 2024 | 44 | 0.210 |
Why?
|
| Tourette Syndrome | 1 | 2025 | 155 | 0.200 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2023 | 13 | 0.200 |
Why?
|
| Gain of Function Mutation | 1 | 2024 | 115 | 0.200 |
Why?
|
| Myoclonus | 1 | 2023 | 31 | 0.200 |
Why?
|
| Treatment Outcome | 5 | 2026 | 12936 | 0.190 |
Why?
|
| Sleep Wake Disorders | 1 | 2025 | 204 | 0.190 |
Why?
|
| Loss of Function Mutation | 1 | 2024 | 177 | 0.190 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2022 | 21 | 0.180 |
Why?
|
| Humans | 19 | 2026 | 131163 | 0.180 |
Why?
|
| Child, Preschool | 7 | 2026 | 15110 | 0.180 |
Why?
|
| Self-Injurious Behavior | 1 | 2023 | 67 | 0.180 |
Why?
|
| Niacin | 1 | 2022 | 59 | 0.180 |
Why?
|
| Child | 10 | 2026 | 26341 | 0.180 |
Why?
|
| Levodopa | 1 | 2021 | 92 | 0.170 |
Why?
|
| Parkinsonian Disorders | 1 | 2022 | 76 | 0.170 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2021 | 19 | 0.170 |
Why?
|
| Genetic Therapy | 1 | 2026 | 713 | 0.170 |
Why?
|
| Male | 10 | 2026 | 64957 | 0.160 |
Why?
|
| Iron | 1 | 2023 | 304 | 0.160 |
Why?
|
| Muscle Contraction | 1 | 2021 | 147 | 0.160 |
Why?
|
| Anxiety Disorders | 1 | 2025 | 731 | 0.150 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.140 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 13 | 0.140 |
Why?
|
| Myelitis | 1 | 2018 | 14 | 0.140 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 45 | 0.140 |
Why?
|
| Adolescent | 7 | 2026 | 20987 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2018 | 137 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2024 | 629 | 0.130 |
Why?
|
| Larynx | 1 | 2018 | 74 | 0.130 |
Why?
|
| West Nile virus | 1 | 2018 | 122 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 145 | 0.120 |
Why?
|
| Pedigree | 1 | 2020 | 1677 | 0.120 |
Why?
|
| Chromosome Disorders | 1 | 2018 | 316 | 0.120 |
Why?
|
| Intellectual Disability | 1 | 2023 | 1089 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 653 | 0.110 |
Why?
|
| Female | 9 | 2026 | 70963 | 0.110 |
Why?
|
| Brain | 2 | 2023 | 3175 | 0.110 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 981 | 0.110 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 330 | 0.100 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 530 | 0.100 |
Why?
|
| Mutation | 2 | 2023 | 6099 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17753 | 0.080 |
Why?
|
| Neurosurgical Procedures | 1 | 2010 | 322 | 0.060 |
Why?
|
| Homovanillic Acid | 1 | 2026 | 30 | 0.060 |
Why?
|
| Putamen | 1 | 2026 | 24 | 0.060 |
Why?
|
| Hearing Disorders | 1 | 2025 | 42 | 0.060 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 6 | 0.050 |
Why?
|
| Neurotoxins | 1 | 2023 | 44 | 0.050 |
Why?
|
| Injections | 1 | 2023 | 109 | 0.050 |
Why?
|
| Amines | 1 | 2022 | 34 | 0.050 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2022 | 17 | 0.050 |
Why?
|
| Epilepsy | 1 | 2010 | 876 | 0.050 |
Why?
|
| Genetic Vectors | 1 | 2026 | 892 | 0.050 |
Why?
|
| Ataxia | 1 | 2023 | 160 | 0.040 |
Why?
|
| Caenorhabditis elegans | 1 | 2022 | 251 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2021 | 185 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2022 | 383 | 0.040 |
Why?
|
| Pediatrics | 1 | 2010 | 1252 | 0.040 |
Why?
|
| Recovery of Function | 1 | 2021 | 449 | 0.040 |
Why?
|
| Seizures | 1 | 2023 | 890 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2025 | 3061 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2026 | 5196 | 0.030 |
Why?
|
| Rats | 1 | 2022 | 3370 | 0.030 |
Why?
|
| Syndrome | 1 | 2018 | 1155 | 0.030 |
Why?
|
| Young Adult | 2 | 2024 | 10103 | 0.030 |
Why?
|
| California | 1 | 2010 | 127 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2010 | 321 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 31282 | 0.020 |
Why?
|
| Anticonvulsants | 1 | 2010 | 363 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1378 | 0.020 |
Why?
|
| Animals | 1 | 2022 | 33912 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2010 | 3147 | 0.010 |
Why?
|